Onyx Pharmaceuticals, Inc.

Is this your business?

Get access!

Company Details

Name:	Onyx Pharmaceuticals, Inc.
Jurisdiction:	Rhode Island
Entity type:	Foreign Corporation
Status:	Activ
Date of Organization in Rhode Island:	31 Mar 2006 (19 years ago)
Identification Number:	000155104
Place of Formation:	DELAWARE
Purpose:	BIOPHARMACEUTICAL COMPANY
Principal Address:	ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320, USA

Industry & Business Activity

NAICS

325412 Pharmaceutical Preparation Manufacturing

This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Learn more at the U.S. Census Bureau

Agent

Name	Role	Address
CORPORATION SERVICE COMPANY	Agent	222 JEFFERSON BOULEVARD SUITE 200, WARWICK, RI, 02888, USA

TREASURER

Name	Role	Address
ADAM S. ELINOFF	TREASURER	ONE AMGEN CENTER DRIVE THOUSAND OAKS, CA 91320 USA

VICE PRESIDENT

Name	Role	Address
LISA KATZ GRUBER	VICE PRESIDENT	ONE AMGEN CENTER DRIVE THOUSAND OAKS, CA 91320 USA

SECRETARY

Name	Role	Address
JONATHAN P GRAHAM	SECRETARY	ONE AMGEN CENTER DRIVE THOUSAND OAKS, CA 91320 USA

DIRECTOR

Name	Role	Address
PETER H GRIFFITH	DIRECTOR	ONE AMGEN CENTER DRIVE THOUSAND OAKS, CA 91320 USA
DAVID M REESE	DIRECTOR	ONE AMGEN CENTER DRIVE THOUSAND OAKS, CA 91320 USA
MURDO GORDON	DIRECTOR	ONE AMGEN CENTER DRIVE THOUSAND OAKS, CA 91320 USA

PRESIDENT

Name	Role	Address
JAMES E. BRADNER	PRESIDENT	1 AMGEN CENTER DRIVE THOUSAND OAKS, CA 91320 USA

Filings

Number	Name	File Date
202453111540	Annual Report	2024-04-29
202333612530	Annual Report	2023-04-21
202216523830	Annual Report	2022-05-01
202193218330	Annual Report	2021-02-27
202034583490	Annual Report	2020-02-18

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 28 May 2025

Sources: Rhode Island Department of State